1Department of Pharmacognosy, Career Point University, Hamirpur
2Assistant Professor, Department of Pharmacognosy, Career Point University, Hamirpur
3Associate Professor, Department of Pharmacognosy, Laureate Institute of Pharmacy, Kathog, Jawalamukhi, Himachal Pradesh
*Corresponding Author E-mail: diwansanjay1981@gmail.com
Online published on 17 April, 2024.
The interest in natural and functional food products has increased globally. This review will add to the growing literature for the researchers. The Berberry or Berberis vulgaris, are has a place with the Berberidaceae family which is red shaded organic products developing in the Europe and Asia. A large body of literature supports different pharmacological actions of Berberis vulgaris (B. vulgaris) and its active component, berberine (BBR), such as antidiabetic, antiobesity, hypotensive and hypolipidemic properties that could be interesting in the management of CVD risk. Numerous preclinical in vitro and in vivo studies support all these effects. In this review, we evaluated the most related original articles to discover the role of B. vulgaris on various constituents. This review suggests a potential role of Berberis vulgaris.
Berberis vulgaris, Berberidaceae, Berberine, Pharmacological activities